Stock Financial Ratios, Dividends, Split History

AHGP / Alliance Holdings GP, L.P financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price28.37
Volume72,000.00
Market Cap ($M)1,698.31
Book Value ($M)1,241.45
Book Value / Share20.74
Price / Book1.37
NCAV ($M)-707.91
NCAV / Share-11.83
Price / NCAV-2.40
Share Statistics
Weighted Average Number Diluted Shares Outstanding Adjustment 0
Common Shares Outstanding 59,863,000
Scoring Models
Piotroski F-Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.18
Return on Assets (ROA)0.14
Return on Equity (ROE)0.28
Balance Sheet (mrq) ($M)
Assets2,244.77
Liabilities1,003.32
Quick Ratio0.82
Current Ratio1.15
Income Statement (mra) ($M)
Revenues0.00
Coal Products And Services Revenue1,711,114,000.00
Shipping And Handling Revenue41,700,000.00
Sales Revenue Net1,795,841,000.00
Other Sales Revenue Net43,027,000.00
Operating Income326.66
Net Income302.26
Cash Flow Statement (mra) ($M)
Cash From Operations554.08
Cash from Investing-244.77
Cash from Financing-244.77
Identifiers and Descriptors
CUSIP01861G100
Central Index Key (CIK)1344980
Related CUSIPS
01861G900 01861G950

Split History

Stock splits are used by Alliance Holdings GP, L.P to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

HIMX: Himax Technologies Analysis and Research Report

7h - Asif

History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

Related News Stories

Mailbag: FERC, Reorgs, And Catalysts - 3 Popular MLP Questions With 3 Simple Answers

2018-04-20 seekingalpha
I have a three-year-old little boy, and we're at the stage where the ride to preschool is an open forum for every question you can imagine. "Why are the tags on my shirts so itchy?" and similar. I explain things to him in the simplest terms possible, and it got me to thinking about how sometimes we all need things explained in the simplest terms possible. Yes, you've read about the FERC decision, but can you explain it in a way that your three-year-old (or client who acts like a three-year-old) can understand? My mailbag today attempts to do just that. (13-0)

50 Top Basic Materials Dividend Yields For March

2018-03-27 seekingalpha
Coal, wood, glass, & chemicals topped March's basic materials sector for gains, calculated by broker 1-year targets on 3/23/18. (33-2)

CUSIP: 01861G100